
Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors
Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors https://www.metabolism-cancer.com/wp-content/uploads/2021/05/Poster_Benej_page-0001.jpg 1241 1755 Metabolism & Cancer //www.metabolism-cancer.com/wp-content/uploads/2024/10/METABO_2025_696x696px.png